Barclays lowered the firm’s price target on Amdocs (DOX) to $111 from $113 and keeps an Overweight rating on the shares following the CEO ...
In a report released today, Tavy Rosner from Barclays maintained a Buy rating on Amdocs (DOX – Research Report), with a price target of $111.00. The company’s shares closed yesterday at $87.75.
Q4 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by. Welcome to the Amdocs Limited Fourth ...